@FrezzaLab Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model https://t.co/UxG0DYcyNp Illustrates classic multiple effects of

@MarceloBonini8 The SOD-mimetic nitroxide mito-Tempol is effective against syngeneic breast cancer in rodents. https://t.co/UxG0DYcyNp In humans, TEMPOL itself works against fibrocystic disease of Breast, a sometime forerunner of breast cancer.

@Blagosklonny "Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model" from the FDA (of all people) https://t.co/UxG0DYd6CX

@AshleyGWinter From the FDA (of all places) -- mitotempol shows efficacy in an animal model for breast ca and shows cardioprotection from doxorubicin toxicity. https://t.co/UxG0DYcyNp

@Jeff_Mold 1/3 You can also inhibit cancer cell growth by SOD's and SOD-mimetic drugs such as Tempol, which diminish the oxidative cell growth drive. Paradoxically, Tempol not only inhibits the toxicity of doxorubicin, it is also anticancer. https://t.co

Replying to @Ethan_L_Ostrom and @SFRBM #sfrbm2020 FDA researchers report that mitochondrial-directed SOD-mimetic mitotempol works on rodent breast Ca, perhaps by effectively mimicking the action of Sirt3. https://t.co/UxG0DYcyNp

Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through... http://t.co/KcAMWF7AlS #BreastCancerAwareness

http://t.co/YgVLqWUDJs : Study shows hair loss treatment agent mito-Tempol works in breast cancer in animals http://t.co/PaaxUOCQIC